Portfolio company
Innocens
Belgium
Raised
Undisclosed
Latest stage
Pre-seed
Rounds recorded
1 · 1 undisclosed
Backed by
1 investor
Sectors
About
Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.
SourceFunding history · 1
Similar companies
SIME Clinical AI
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
Aisthesis Medical
The company develops artificial intelligence software that predicts sepsis and patient deterioration for hospitals and clinical teams.
Sencilia
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
Bayesian Health
This company develops an artificial intelligence platform for hospitals to detect early signs of patient deterioration and life-threatening conditions such as sepsis.
Insentio
The company develops artificial intelligence technology for the rapid identification of infectious bacteria to assist healthcare providers and laboratories.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
Siloam Vision
This company develops AI-enabled retinal imaging systems and diagnostic software for healthcare providers to detect preventable blindness in neonates and adults.
NEX Health Intelligence
NEX Health Intelligence develops an artificial intelligence platform for hospitals to detect, predict and prevent healthcare-associated infections.
